Torrent Pharma Latest News

  1. The reason for the recalls is CGMP Deviations as FDA lab confirmed presence of an impurity
    Date:14-10-2019
  2. The agency had classified its inspection as ‘Official Action Indicated’
    Date:10-10-2019
  3. The agency had classified its inspection as ‘Official Action Indicated’
    Date:10-10-2019
  4. The company has redeemed Commercial Paper worth Rs 100 crore
    Date:25-09-2019
  5. Torrent Pharmaceuticals has informed about transfer of shares of the Company pursuant to SEBI Circular No. SEBI/H0/MIRSD/DOS3/CIR/P/2018/139 dated November 6, 2018 on ‘Standardized norms for transfer of securities in physical mode&rsqu...

    Date:25-09-2019
  6. The instrument was issued on May 17, 2019
    Date:24-09-2019
  7. The instrument was issued on May 17, 2019
    Date:24-09-2019
  8. The company is expanding recall for Losartan potassium tablets USP and Losartan potassium / hydrochlorothiazide tablets
    Date:23-09-2019
  9. The tenure of the instrument is 1080 days
    Date:17-09-2019
  10. The instrument was issued on May 03, 2019
    Date:17-09-2019
Return to Top
Puchho Befikar